Search Results

INF39 10mg  | ≥99%

CSNpharm

INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.

More Information Supplier Page

(±)-SLV319 5mg  | ≥99%

CSNpharm

(±)-SLV319 is a selective antagonist of cannabinoid-1 (CB1) receptor with Ki value of 7.8 nM and it has a weaker activation effect on CB2.

More Information Supplier Page

(±)-SLV319 10mg  | ≥99%

CSNpharm

(±)-SLV319 is a selective antagonist of cannabinoid-1 (CB1) receptor with Ki value of 7.8 nM and it has a weaker activation effect on CB2.

More Information Supplier Page

(±)-SLV319 100mg  | ≥99%

CSNpharm

(±)-SLV319 is a selective antagonist of cannabinoid-1 (CB1) receptor with Ki value of 7.8 nM and it has a weaker activation effect on CB2.

More Information Supplier Page

Sacubitrilat 50mg  | ≥99%

CSNpharm

Sacubitrilat, namely LBQ-657, is an inhibitor of endopeptidase and effective for hypertension and heart failure. Sacubitrilat is one of the impurities of sacubitril.

More Information Supplier Page

Sacubitrilat 10mg  | ≥99%

CSNpharm

Sacubitrilat, namely LBQ-657, is an inhibitor of endopeptidase and effective for hypertension and heart failure. Sacubitrilat is one of the impurities of sacubitril.

More Information Supplier Page

Sacubitrilat 1mg  | ≥99%

CSNpharm

Sacubitrilat, namely LBQ-657, is an inhibitor of endopeptidase and effective for hypertension and heart failure. Sacubitrilat is one of the impurities of sacubitril.

More Information Supplier Page

(±)-SLV319 50mg  | ≥99%

CSNpharm

(±)-SLV319 is a selective antagonist of cannabinoid-1 (CB1) receptor with Ki value of 7.8 nM and it has a weaker activation effect on CB2.

More Information Supplier Page